Minimal Invasive Spinal Devices - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Minimal Invasive Spinal Devices Overview

3 Products under Development

• 3.1 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
• 3.2 Minimal Invasive Spinal Devices - Pipeline Products by Segment
• 3.3 Minimal Invasive Spinal Devices - Pipeline Products by Territory
• 3.4 Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
• 3.5 Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date

4 Minimal Invasive Spinal Devices - Pipeline Products under Development by Companies

• 4.1 Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
• 4.2 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimal Invasive Spinal Devices Companies and Product Overview

• 5.1 Bonovo Orthopedics Inc Company Overview
• 5.2 Camber Spine Technologies LLC Company Overview
• 5.3 Corelink LLC Company Overview
• 5.4 DePuy Synthes Inc Company Overview
• 5.5 EIT Emerging Implant Technologies GmbH Company Overview
• 5.6 Inion Oy Company Overview
• 5.7 Integra LifeSciences Holdings Corp Company Overview
• 5.8 KISCO International Company Overview
• 5.9 Maxigen Biotech Inc Company Overview
• 5.10 Medicrea Group Company Overview
• 5.11 Medyssey Co Ltd Company Overview
• 5.12 MicroPort Scientific Corp Company Overview
• 5.13 OxSonics Ltd Company Overview
• 5.14 Safe Orthopaedics SA Company Overview
• 5.15 SeaSpine, Inc. Company Overview
• 5.16 Sheba Medical Center Company Overview
• 5.17 Solco Biomedical Co Ltd Company Overview
• 5.18 Spinal Balance Inc. Company Overview
• 5.19 Stryker Corp Company Overview
• 5.20 University of South Florida Company Overview
• 5.21 Vivonics Inc Company Overview

6 Minimal Invasive Spinal Devices- Recent Developments

• 6.1 Aug 22, 2019: Aurora Spine reports record Q2 revenue; files condensed interim consolidated financial statements for the three and six months ended June 30, 2019
• 6.2 Aug 13, 2019: FDA OKs Solco’s spinal fixation system
• 6.3 Aug 06, 2019: joimax and Red One Medical partner to support expert endoscopic minimally invasive spine surgery for veterans and active military
• 6.4 Jul 15, 2019: joimax starts the official sale of its EndoLIF Delta and DoubleWedge cages. All three members of EndoLIF family CE approved.
• 6.5 Jul 09, 2019: Medicrea reports first half 2019 sales
• 6.6 Jun 17, 2019: MEDICREA secures several new patents to protect its proprietary platform technology UNiD ASI
• 6.7 May 30, 2019: Aurora Spine reports record Q1 revenue
• 6.8 May 17, 2019: Medicrea announces first quarter 2019 financial results
• 6.9 May 14, 2019: Medicrea hosts second annual meeting focused on Artificial Intelligence and Analytics in New York, USA
• 6.10 Apr 26, 2019: Aurora Spine announces 2018 year end results
• 6.11 Apr 18, 2019: MEDICREA enhances its proprietary UNiD ASI Service Platform with the addition of an FDA-Cleared device planning and selection service
• 6.12 Apr 10, 2019: Medicrea reports first quarter 2019 sales
• 6.13 Mar 28, 2019: SpineGuard receives regulatory Clearance in Taiwan and starts PediGuard commercialization
• 6.14 Mar 22, 2019: Medicrea announces 2018 annual results
• 6.15 Mar 13, 2019: Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
• 6.16 Mar 12, 2019: joimax hosts international training summit to showcase innovative technologies
• 6.17 Feb 12, 2019: Dr. Raymond Gardocki of the Campbell Clinic in Memphis, TN, performs his 100th endoscopic spine surgery utilizing joimax technologies
• 6.18 Feb 08, 2019: joimax announces new distribution partners in Brazil and Japan
• 6.19 Jan 23, 2019: Aurora Spine announces new patent for its Minimally Invasive Spinal Implants allowed by the United States Patent Office
• 6.20 Jan 16, 2019: Medicrea reports 2018 fourth quarter and annual sales
• 6.21 Nov 22, 2018: Aurora Spine Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2018
• 6.22 Nov 19, 2018: MEDICREA achieves 3,000 surgery milestone with UNiD ASI and patient specific implants
• 6.23 Nov 15, 2018: Medicrea reports third-quarter results
• 6.24 Nov 05, 2018: Medicrea to attend the 9th Annual Craig-Hallum Alpha Select Conference
• 6.25 Nov 05, 2018: Rapid company growth prompts joimax to move its US headquarters to a new, larger state-of-the-art facility
• 6.26 Oct 22, 2018: Medline awarded lab distribution agreement with Premier
• 6.27 Oct 10, 2018: Leading into SRS 2018, Medicrea highlights a new study showing that patients implanted with UNiD patient-specific rods are 2.6 times more likely to be optimally corrected

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us